BRCB Jumps 35.9%, EAF 22.4% on EPS Revisions: Top Gainers

Black Rock Coffee Bar (BRCB) led our EPS-revision screener with a 35.9% gain to $9.81 after its next-year EPS growth estimate rose to 30.0% on October 14, while GrafTech (EAF) added 22.4% to $8.51 after guiding to a Q4 pricing inflection. Hudson Pacific (HPP) rose 21.9%, Alamar Biosciences (ALMR) 21.0%, and HubSpot (HUBS) 19.7%, as upward estimate revisions preceded strong price confirmation across Consumer Cyclical, Industrials, Real Estate, Healthcare, and Technology.

Ticker Sector Detected EPS Revision Gain Since Detection
BRCBConsumer Cyclical2026-10-14+1.3pp+35.9%
EAFIndustrials2026-10-20N/A+22.4%
HPPReal Estate2026-10-19N/A+21.9%
ALMRHealthcare2026-10-14+3.8pp+21.0%
HUBSTechnology2026-10-14N/A+19.7%

Why did BRCB stock jump in October 2026?

BRCB jumped 35.9% (from $7.22 to $9.81) after its next-year EPS growth estimate was revised to 30.0% from 28.7% on October 14.

The 1.3-percentage-point upward revision was enough to flag the coffee chain on our EPS screener, and buyers piled in over the following nine trading days. With no company-specific earnings news in the window, the move looks like estimate-driven accumulation in a Consumer Cyclical name whose unit-growth story is gaining traction. The rally extended without a single headline catalyst, a sign that the revision itself became the narrative.

FAQ: BRCB

Why did BRCB stock jump?

BRCB rose 35.9% from $7.22 to $9.81 after its next-year EPS growth estimate was revised up to 30.0% on October 14, with no offsetting earnings news.

What is BRCB's EPS growth estimate?

Black Rock Coffee Bar's next-year EPS growth estimate stands at 30.0%, up from 28.7% before the October 14 revision.

Is BRCB a buy after the 35.9% rally?

The move was estimate-driven with no news catalyst, so the risk/reward has shifted; a 30.0% next-year EPS growth estimate still supports the story if the company delivers.

Why did EAF stock jump in October 2026?

EAF jumped 22.4% (from $6.95 to $8.51) after management guided to a mid-single-digit Q4 price increase on October 23, reinforcing a 35.0% next-year EPS growth estimate.

The quarter itself was messy: an adjusted loss of $1.21 per share beat the -$1.46 consensus by 17.1%, and revenue of $140.16 million topped estimates by 10.7%, but GAAP losses widened to $1.76 per share. The inflection argument carried the stock: adjusted EBITDA climbed sequentially from -$22 million in Q4 2025 to $9 million, and GrafTech is closing its high-cost Monterrey plant. The balance sheet remains the constraint, with $9 million of EBITDA still short of the interest bill, but the market paid for the trajectory rather than the quarter.

FAQ: EAF

Why did EAF stock surge on October 23?

EAF gained 22.4% to $8.51 after Q3 revenue beat estimates by 10.7% and management guided to a mid-single-digit Q4 price increase, confirming a pricing inflection.

What is EAF's EPS growth estimate?

GrafTech's next-year EPS growth estimate is 35.0%, and the Q3 adjusted loss of $1.21 per share beat the -$1.46 consensus by 17.1%.

Is EAF a buy after the rally?

EAF's adjusted EBITDA improved to $9 million from -$22 million in Q4 2025, but that still doesn't cover interest expense, so the pricing inflection must hold before the equity story is de-risked.

Why did HPP stock jump in October 2026?

HPP jumped 21.9% (from $9.02 to $11.00) after its next-year EPS growth estimate of 30.5% flagged it on our screener on October 19.

No earnings-related news surfaced in the window, so the gain reflects a pure estimate-revision trade in the Real Estate sector. The move suggests investors are re-rating office and studio REIT cash flows as occupancy expectations stabilize. Detection at $9.02 caught the turn early; the 21.9% follow-through is the market confirming the revised growth outlook.

FAQ: HPP

Why did HPP stock jump?

HPP climbed 21.9% to $11.00 after its next-year EPS growth estimate of 30.5% triggered our screener on October 19, with no company-specific news in the period.

What is HPP's EPS growth estimate?

Hudson Pacific Properties' next-year EPS growth estimate is 30.5%, the level that flagged the stock on October 19.

Is HPP a buy after the rally?

The 21.9% move happened without a news catalyst, so the revised 30.5% growth estimate is now partly priced in; further upside depends on the next earnings report confirming the outlook.

Why did ALMR stock jump in October 2026?

ALMR jumped 21.0% (from $25.37 to $30.69) after its next-year EPS growth estimate rose 3.8 percentage points to 49.1% on October 14, the largest revision among today's gainers.

No earnings news accompanied the move, so the rally in the Healthcare name was driven by estimate momentum alone. A near-50% growth estimate puts Alamar among the fastest-growing companies in the screener, and buyers acted on that before any headline confirmation. The 21.0% gain over seven trading days shows how quickly a large revision can reprice a mid-cap with limited coverage.

FAQ: ALMR

Why did ALMR stock jump?

ALMR rose 21.0% to $30.69 after its next-year EPS growth estimate was revised up 3.8 percentage points to 49.1% on October 14.

What is ALMR's EPS growth estimate?

Alamar Biosciences' next-year EPS growth estimate is 49.1%, up from 45.3% before the October 14 revision.

What caused ALMR's surge?

The surge was driven by an estimate revision rather than news: the 3.8-percentage-point upgrade to 49.1% growth on October 14 preceded a 21.0% price move to $30.69.

Why did HUBS stock jump in October 2026?

HUBS jumped 19.7% (from $226.23 to $270.88) after its next-year EPS growth estimate of 27.0% flagged it on our screener on October 14.

The stock rallied into its November 4 Q3 earnings date, which the company announced on October 21, with no interim results released. Investors used the estimate revision as a reason to position ahead of the print, and the Technology sector's appetite for profitable growth names did the rest. Detection at $226.23 was early; the 19.7% run to $270.88 reflects the market pricing in a confident report.

FAQ: HUBS

Why did HUBS stock jump?

HUBS rose 19.7% to $270.88 after its 27.0% next-year EPS growth estimate triggered our screener on October 14, with buyers positioning ahead of Q3 results on November 4.

What is HUBS's EPS growth estimate?

HubSpot's next-year EPS growth estimate is 27.0%, the level that flagged the stock on October 14.

When does HUBS report Q3 2026 earnings?

HubSpot will report third-quarter 2026 financial results after market close on November 4, 2026, with a call at 4:30 p.m. Eastern.

Today's leaders share a clear pattern: estimate revisions came first, and price followed within days, even without company news (BRCB, HPP, ALMR) or before the print (HUBS). EAF shows the same dynamic reinforced by a genuine pricing catalyst, suggesting markets are rewarding forward-earnings momentum across sectors rather than any single theme.

How We Identify These Stocks

We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.

Explore today's full screener →